share_log

Pharmala Biotech Holdings Inc: REPORT OF EXEMPT DISTRIBUTION EXCLUDING SCHEDULE 1 OF 45-106F1

SEDAR ·  May 26, 2021 08:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more